Company
Mass General Brigham Ventures
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Claris Biotherapeutics, Inc. | Series B | 2026-08-03 | |
| Violet Therapeutics | Seed Extension | 2026-05-19 | |
| Affinia Therapeutics | Series C | 2025-10-08 | |
| Predicta Biosciences | Series A | 2025-10-02 | Lead |
| Carta Healthcare | Series B1 | 2025-05-07 | |
| Abcuro | Series C | 2025-02-13 | |
| Rippl | Series A Funding | 2024-10-04 | |
| Nocion Therapeutics Extends Series B Financing to $93M | Series B Financing | 2024-03-06 | |
| Abcuro | Series B Financing | 2023-08-18 | |
| Mediar Therapeutics | Funding | 2023-03-15 | |
| Garuda Therapeutics | Series B | 2023-02-07 | |
| Rippl | Seed | 2022-09-28 | |
| Photys Therapeutics | Series A | 2022-09-08 |